Skip to search form
Skip to main content
Skip to account menu
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
3,4-dihydroxyethylamphetamine
Known as:
(OH)2-Et-amphetamine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Amphetamines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Investigations on the stereoselectivity of the phase II metabolism of the 3,4-methylenedioxyethylamphetamine (MDEA) metabolites 3,4-dihydroxyethylamphetamine (DHEA) and 4-hydroxy-3…
Andrea E. Schwaninger
,
M. Meyer
,
J. Zapp
,
H. Maurer
Toxicology letters
2012
Corpus ID: 22811744
Different elimination was reported for the two enantiomers of the designer drug 3,4-methylenedioxyethylamphetamine (MDEA) in vivo…
Expand
Highly Cited
1996
Highly Cited
1996
Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Isolation, identification, quantification, and synthesis of urinary metabolites.
H. Ensslin
,
H. Maurer
,
E. Gouzoulis
,
L. Hermle
,
K. Kovar
Drug metabolism and disposition: the biological…
1996
Corpus ID: 28725216
Studies on the isolation, identification, quantification, and synthesis of the urinary metabolites of racemic 3,4…
Expand
Highly Cited
1996
Highly Cited
1996
Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization…
H. Ensslin
,
K. Kovar
,
H. Maurer
Journal of chromatography. B, Biomedical…
1996
Corpus ID: 8890461
Studies are presented on the toxicological detection of the designer drug methylenedioxyethylamphetamine [MDE, rac-N-ethyl-(3,4…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE